Last reviewed · How we verify

NCT03431844

Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation

Completed Last updated 5 August 2020
What this trial tests

trial in Myocardial Ischemia in 106 participants. Completed in 31 August 2019.

Timeline
1 January 2018
Primary endpoint
31 August 2019
31 August 2019

Quick facts

Lead sponsorUniversity of Tartu
StatusCompleted
Study typeOBSERVATIONAL
Enrollment106
Start date1 January 2018
Primary completion31 August 2019
Estimated completion31 August 2019
Sites2 locations across Estonia

Conditions studied

Sponsor

University of Tartu

Who can join

18 and older, any sex, with Myocardial Ischemia or Coronary Artery Bypass Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective of the study is to clarify humanin-like peptide concentration in myocard tissue and in blood and to study if its concentration level is related to early complication occurrence and frequency after cardiac operation. Hypothesis of the study is that previously described elements are related to each other.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Mitochondrial Targeted Interventions for Aging.
    Liu SZ, Chiao YA, Rabinovitch PS, Marcinek DJ. · · 2024 · cited 8× · PMID 37788882 · DOI 10.1101/cshperspect.a041199

Verify or expand the search:

Other recruiting trials for Myocardial Ischemia

Currently open trials in the same condition.

Other University of Tartu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03431844.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing